GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $21.93 $29.93 Thursday, 18th Apr 2024 ARWR stock ended at $22.61. This is 0.355% more than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 3.97% from a day low at $21.93 to a day high of $22.80.
90 days $21.93 $36.72
52 weeks $20.67 $42.48

Historical Arrowhead Research Corporation prices

Date Open High Low Close Volume
2023-10-18 $26.82 $27.14 $25.78 $25.99 1 017 202
2023-10-17 $25.93 $27.68 $25.88 $27.02 1 205 600
2023-10-16 $26.76 $26.84 $25.99 $26.51 851 402
2023-10-13 $26.00 $26.72 $25.89 $26.60 944 838
2023-10-12 $26.54 $26.60 $25.85 $25.88 1 288 342
2023-10-11 $25.44 $26.49 $25.34 $26.46 1 157 247
2023-10-10 $24.87 $25.66 $24.53 $25.63 910 146
2023-10-09 $24.97 $25.10 $24.19 $24.97 591 315
2023-10-06 $25.25 $25.80 $25.01 $25.19 621 002
2023-10-05 $23.48 $25.57 $23.44 $25.55 1 644 469
2023-10-04 $25.26 $25.58 $23.63 $23.77 1 281 440
2023-10-03 $26.07 $26.12 $24.65 $25.16 1 087 144
2023-10-02 $26.52 $26.69 $25.94 $26.25 1 343 870
2023-09-29 $27.13 $27.41 $26.35 $26.87 806 416
2023-09-28 $26.33 $27.31 $26.04 $26.93 759 799
2023-09-27 $26.37 $26.66 $26.08 $26.39 643 000
2023-09-26 $26.75 $27.32 $26.19 $26.20 1 046 058
2023-09-25 $26.98 $27.12 $26.37 $26.67 640 540
2023-09-22 $27.28 $27.64 $27.04 $27.24 574 631
2023-09-20 $27.25 $27.49 $26.89 $27.01 820 225
2023-09-19 $28.02 $27.94 $27.16 $27.23 612 294
2023-09-18 $28.94 $29.05 $27.51 $28.13 824 982
2023-09-15 $30.59 $30.73 $28.88 $28.92 1 798 363
2023-09-14 $29.55 $31.14 $29.31 $30.54 1 033 841
2023-09-13 $29.11 $29.70 $29.07 $29.34 715 044
Click to get the best stock tips daily for free!

About Arrowhead Research Corporation

Arrowhead Research Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is in phase 2b and one phase 3 clinical trial to treat hypertriglyceridemia; ARO-ANG3 that is in P... ARWR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT